Е. Л. Насонов

2.8k citations

51 papers · 1.9k indexed · 1 hit paper · h-index 12

Rheumatology top 0.5%
Immunology top 2%
Radiology, Nuclear Medicine and Imaging top 2%
Pathology and Forensic Medicine top 10%
Hematology top 5%

Co-authors: Mathew Thomas Stephen Hall A Gallacher Roger A. Levy Z. John Zhong Joung-Liang Lan C Tănăsescu Ho‐Youn Kim
Topics: Rheumatoid Arthritis Research and Therapies (22 papers)Systemic Lupus Erythematosus Research (14 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)
Cited by: Rheumatology Immunology Radiology, Nuclear Medicine and Imaging
Journals: The LancetSHILAP Revista de lepidopterologíaAnnals of the Rheumatic Diseases
Partner nations: Russia United States Switzerland

In The Last Decade

Е. Л. Насонов

40 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

2011 1.4k citations Sandra Navarra, Renato Guzmán et al. The Lancet profile →

Peers

Countries citing papers authored by Е. Л. Насонов

Since Specialization

Citations

This map shows the geographic impact of Е. Л. Насонов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. Л. Насонов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. Л. Насонов more than expected).

Fields of papers citing papers by Е. Л. Насонов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. Л. Насонов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. Л. Насонов. The network helps show where Е. Л. Насонов may publish in the future.

Co-authorship network of co-authors of Е. Л. Насонов

This figure shows the co-authorship network connecting the top 25 collaborators of Е. Л. Насонов. A scholar is included among the top collaborators of Е. Л. Насонов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. Л. Насонов. Е. Л. Насонов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Problems of providing medical care to the population in the profile of rheumatology: results of the all-Russian survey 2024 ·Voprosy praktičeskoj pediatrii ·Е. Л. Насонов,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Е.I. Alexeeva,(unknown)	0
2	Indicators of rheumatoid arthritis disease activity. An association with a patient’s psychological status 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),Е. Л. Насонов	3
3	Systemic lupus erythematosus: new horizons for diagnosis and therapy 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Т. В. Попкова,А. М. Лила,Mazurov Vi,Е. Л. Насонов	16
4	The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence 2019 ·SHILAP Revista de lepidopterología ·Е. Л. Насонов,А. М. Лила	8
5	PROSPECTS FOR ANTI-B-CELL THERAPY IN RHEUMATOLOGY 2018 ·SHILAP Revista de lepidopterología ·Е. Л. Насонов	7
6	Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases 2018 ·Terapevticheskii arkhiv ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Z S Alekberova,В. Краснов,Е. Л. Насонов	15
7	EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION 2015 ·SHILAP Revista de lepidopterología ·(unknown),Д. С. Новикова,Т. В. Попкова,(unknown),(unknown),(unknown),(unknown),А. В. Волков,Е. Л. Лучихина,(unknown),(unknown),(unknown),(unknown),(unknown),А. А. Новиков,Е Н Александрова,Д. Е. Каратеев,Е. Л. Насонов	1
8	RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2 2015 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),Е. Л. Насонов	0
9	NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE 2015 ·SHILAP Revista de lepidopterología ·Е. Л. Насонов,Д. Е. Каратеев,Н. В. Чичасова	2
10	CHANGES IN HEART RATE, HEART RATE VARIABILITY AND QT INTERVAL IN WOMEN WITH RHEUMATOID ARTHRITIS DURING RITUXIMAB TREATMENT 2014 ·SHILAP Revista de lepidopterología ·Д. С. Новикова,Т. В. Попкова,Е. В. Герасимова,А. А. Новиков,Е Н Александрова,Е. Л. Насонов	1
11	New possibilities of pharmacotherapy for systemic lupus erythematosus: A place of belimumab 2014 ·Modern Rheumatology Journal ·Е. Л. Насонов	1
12	ASSOCIATION BETWEEN HEART RATE VARIABILITY AND COMPONENTS OF THE METABOLIC SYNDROME IN WOMEN WITH RHEUMATOID ARTHRITIS 2014 ·Rational Pharmacotherapy in Cardiology ·Д. С. Новикова,Т. В. Попкова,(unknown),А. В. Волков,Е. Л. Насонов	1
13	Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia 2013 ·Clinical Rheumatology ·Anton Lennikov,Z S Alekberova,(unknown),Nobuyoshi Kitaichi,(unknown),Kenichi Namba,Mitsuhiro Takeno,Yoshiaki Ishigatsubo,Nobuhisa Mizuki,Е. Л. Насонов,Susumu Ishida,Shigeaki Ohno	11
14	Proinflammatory cytokines and depression in rheumatoid arthritis 2013 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),А. А. Новиков,Е Н Александрова,В. Краснов,Е. Л. Насонов	5
15	AB0299 Association of basal level antibodies to modified citrullinated vimentin (anti-mcv) with joint destruction in rheumatoid arthritis (ra) patients during the tocilizumab (tcz) therapy 2013 ·Annals of the Rheumatic Diseases ·А. С. Авдеева,(unknown),(unknown),А. А. Новиков,(unknown),(unknown),Е. Л. Насонов	0
16	Immunogenetic Aspects оf Early Rheumatoid Arthritis 2013 ·Annals of the Russian academy of medical sciences ·(unknown),(unknown),(unknown),А. А. Новиков,Е. Л. Лучихина,Е Н Александрова,G. Lukina,(unknown),(unknown),(unknown),(unknown),D. Yu. Trofimov,Д. Е. Каратеев,Е. Л. Насонов	1
17	4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS 2011 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Е. Л. Насонов	1
18	Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialbreakdown → 2011 ·The Lancet ·Sandra Navarra,Renato Guzmán,A Gallacher,Stephen Hall,Roger A. Levy,(unknown),(unknown),Mathew Thomas,Ho‐Youn Kim,(unknown),C Tănăsescu,Е. Л. Насонов,Joung-Liang Lan,Lilia Pineda,Z. John Zhong,William W. Freimuth,Michelle Petri	1401
19	Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating, single‐ and repeated‐dose study 2007 ·Arthritis & Rheumatism ·P. P. Tak,Rogier M. Thurlings,(unknown),Ivan Nestorov,(unknown),(unknown),Maureen Rischmueller,Е. Л. Насонов,Е. Шмидт,Paul Emery,Alain Munafo	171
20	C3a and C5a Anaphylatoxins Bind to Heparin‐Based Sorbent in Low Density Lipoprotein Apheresis: In Vitro and In Vivo Investigations 1992 ·Artificial Organs ·(unknown),(unknown),(unknown),(unknown),Е. Л. Насонов,(unknown),В. В. Кухарчук	5

About Е. Л. Насонов

Е. Л. Насонов is a scholar working on Rheumatology, Anatomy and Biological Psychiatry, having authored 51 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Systemic Lupus Erythematosus Research (14 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Rheumatology (1.5k citations), Immunology (1.1k citations) and Radiology, Nuclear Medicine and Imaging (778 citations). Е. Л. Насонов has collaborated with scholars based in Russia, United States and Switzerland. Frequent co-authors include Mathew Thomas, Stephen Hall, A Gallacher, Roger A. Levy, Z. John Zhong, Joung-Liang Lan, C Tănăsescu, Ho‐Youn Kim, Renato Guzmán and Sandra Navarra. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact